 Connection
Jordan Karlitz to Retrospective Studies
This is a "connection" page, showing publications Jordan Karlitz has written about Retrospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.389 |
|
|
|
-
Greene M, Stieber B, Ozbay AB, Anderson J, LeMaster J, Dore M, Stukalin I, Arroyo J, Ebner DW, Fendrick AM, Karlitz JJ. Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. J Natl Compr Canc Netw. 2026 Jul; 24(7).
Score: 0.067
-
Greene M, Stieber B, LeMaster JW, Idriss R, Stukalin I, Zapatier J, Arroyo J, Anderson J, Karlitz JJ. Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type. Curr Med Res Opin. 2025 Sep; 41(9):1629-1639.
Score: 0.064
-
Greene M, Gohil S, Stieber B, Ozbay AB, Le QA, Kakuturu R, LeMaster JW, Dore M, Fendrick AM, Anderson JC, Karlitz JJ. Utilization of colorectal cancer screening modalities in the United States (2017-2023): a national multi-payer claims database analysis. Curr Med Res Opin. 2025 Sep; 41(9):1619-1628.
Score: 0.064
-
Karlitz JJ, Phillips A, Sorrells KS, Rao S. Genetic Analysis of Archived Tumor Specimens for Hereditary Colorectal Cancer Syndromes in the Cajuns of Louisiana, a US Founder Population. Clin Transl Gastroenterol. 2021 09 21; 12(9):e00392.
Score: 0.048
-
Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Ann Intern Med. 2021 02; 174(2):157-166.
Score: 0.046
-
Greene M, Camardo M, Karlitz JJ, Nowd P, Wang W, Anderson J, Kisiel J, Ebner D. Real-world adherence to multi-target stool DNA testing and its association with time to follow-up colonoscopy: a health-system analysis from Massachusetts General Hospital. Curr Med Res Opin. 2026 Feb; 42(2):205-219.
Score: 0.016
-
Greene M, Camardo M, Karlitz JJ, Nowd P, Son J, Fuerstein J, Li J, Rittner S. Adherence to multi-target stool DNA test and time to follow-up colonoscopy: real-world analysis of patients from the Beth Israel Lahey Health. Curr Med Res Opin. 2025 Oct; 41(10):1811-1823.
Score: 0.016
-
Greene M, Anderson J, LeMaster J, Arroyo J, Zapatier J, Bingham J, Kakuturu R, Karlitz JJ, Le Q. Real-World Adherence to Repeat Colorectal Cancer Screening With the Multi-Target Stool DNA Test in a Large, Insured, and Average-Risk Population. Cancer Med. 2025 Nov; 14(21):e71314.
Score: 0.016
-
Greene M, Le QA, Ozbay AB, Karlitz JJ, Fendrick AM. Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopy. Curr Med Res Opin. 2025 Sep; 41(9):1697-1703.
Score: 0.016
-
Gohil S, D'Attilio D, Paladiya R, Ganguly A, Vergara CM, Karlitz JJ, Greene M. Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system. Int J Colorectal Dis. 2025 Sep 16; 40(1):200.
Score: 0.016
-
Zhou M, Thompson TD, Lin HY, Chen VW, Karlitz JJ, Fontham ETH, Theall KP, Zhang L, Hsieh MC, Pollack LA, Wu XC. Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients. Clin Colorectal Cancer. 2022 06; 21(2):e62-e75.
Score: 0.012
-
Chen VW, Hsieh MC, Charlton ME, Ruiz BA, Karlitz J, Altekruse SF, Ries LA, Jessup JM. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014 Dec 01; 120 Suppl 23:3793-806.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|